Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-02

FDA Approved: NEVIRAPINE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Amneal Pharmaceuticals LLC's nevirapine product, updating an already approved generic antiretroviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)